Continuing Medical Education
Who Should Attend
This educational activity is designed for medical oncologists, infectious disease specialists, hematologists, hospitalists, and other physicians, physicians-in-training, and healthcare professionals interested and/or involved in the care of patients with febrile neutropenia.
Objectives
Upon completion of this activity, participants should be able to:
- Discuss and evaluate the clinical use of prophylactic versus empiric or preemptive therapy of fungal infections in febrile neutropenic patients
- Discuss the appropriate selection and practical utilization of replacement antibiotics for therapy of infections caused by resistant bacteria in febrile neutropenic patients
- Describe the role of native immunity on susceptibility and severity of infection in patients with febrile neutropenia
- Identify and assess management strategies for infections in patients undergoing stem cell transplant from alternative sources and donors
- Compare current and emerging therapies in the prevention and management of patients with febrile neutropenia
Elias Anaissie, MD
University of Arkansas School of Medical Sciences
Little Rock, Arkansas, United States
Mickael Aoun, MD
Jules Bordet Institute
Brussels, Belgium
Nicole Blijlevens, MD
St. Raboud University Medical Center
Nijmegen, The Netherlands
Catherine Cordonnier, MD
Hôpital Henri Mondor
Créteil, France
Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg
J. Peter Donnelly, PhD
St. Raboud University Medical Center
Nijmegen, The Netherlands
Aspasia Georgala, MD
Jules Bordet Institute
Brussels Belgium
Jean A. Klastersky, MD, PhD
Jules Bordet Institute
Brussels, Belgium
Ofer Levy, MD, PhD
Harvard Medical School
Boston, Massachusetts, United States
Louis B. Rice, MD
Louis Stokes Cleveland
VA Medical Center
Cleveland, Ohio, United States
Jaime Sanz, MD
University Hospital La Fe
Valencia, Spain
Miguel A. Sanz, MD, PhD
University Hospital La Fe
Valencia, Spain
Wilfried A. M. Schroyens MD, PhD
University Hospital Antwerp
Antwerp, Belgium
Thomas J. Walsh, MD
National Cancer Institute
Bethesda, Maryland, United States
John R. Wingard, MD
University of Florida
Gainesville, Florida, United States
Friday, 12 March 2010
8:00
Introduction
Session I: Prophylactic versus empiric or preemptive therapy of fungal infections
Chair: J. Peter Donnelly, PhD
Co-Chair: Nicole Blijlevens, MD
8:10
State-of-the art lecture: Pre-emptive versus empirical anti-fungal therapy in neutropenic cancer patients
Catherine Cordonnier, MD
8:55
Discussion
9:10
Break
9:30
Oral abstracts
10:20
Case presentation
Thomas J. Walsh, MD
11:10
Session chair’s summary
J. Peter Donnelly, PhD
11:15
Lunch break
Session II: Replacement antibiotics for therapy of infections caused by resistant bacteria
Chair: Jean A. Klastersky, MD, PhD
Co-Chair: Wilfried A. M. Schroyens MD, PhD
13:30
State-of-the art lecture: Treatment of antibiotic-resistant bacteria: A major challenge for the next decade
Louis B. Rice, MD
14:15
Discussion
14:30
Break
14:50
Oral abstracts
15:40
Case presentation:
Mickael Aoun, MD and Aspasia Georgala, MD
16:30
Session Chair’s summary
Jean A. Klastersky, MD, PhD
16:40
Adjourn
Saturday, 13 March 2010
8:00
Welcome and introduction to day two
Mario Dicato, MD
Session III: The role of native immunity on susceptibility and severity of infection
Chair: John R. Wingard, MD
Co-Chair: Mario Dicato, MD
8:10
State-of-the art lecture: Why do some
neutropenic patients get sick and others do not? The role of innate immunity polymorphisms
Elias Anaissie, MD
8:55
Discussion
9:10
Break
9:30
Oral abstracts
10:20
Case presentation
Ofer Levy, MD, PhD
11:10
Session chair’s summary
John R. Wingard, MD
11:15
Lunch break
Session IV: Infections related to alternative transplant procedures
Chair: Miguel A. Sanz, MD, PhD
Co-Chair: John R. Wingard, MD
13:30
State-of-the art lecture: Infections in patients undergoing stem cell transplant from alternative sources and donors
Miguel A. Sanz, MD, PhD
14:15
Discussion
14:30
Break
14:50
Oral abstracts
15:40
Case presentation:
Jaime Sanz, MD
16:30
Session Chair’s summary
Miguel A. Sanz, MD, PhD
16:40
Adjourn with summary by Chair and Local Chair
Jean A. Klastersky, MD, PhD and Mario Dicato, MD
Call for Abstracts
Participants interested in presenting data should first register or log in, then submit abstracts online by 19 January 2010. Abstracts are subject to acceptance by the Scientific Committee.
Abstract Guidelines
• Follow the online instructions
• Abstracts must be written in English
• Accepted format: Word document format, 9 point Arial font, 500 word count limit
• Use a concise title
• List affiliations of author(s) as briefly as possible, with city, state and country
• Place an asterisk (*) before the name of the presenting author
• Use standard and well-accepted abbreviations
• When using references, use standard and well-accepted formats
• Abstract content should be single-spaced, typed in lower case and contain:
| |
– Purpose of the study |
| – Summarized description of the project |
| – Results and conclusions |
Submission Deadline - Extended!
19 January 2010
Registration Fees
Discounted
Payment received by 19 January 2010 |
€550 |
Regular
Payment received by 4 March 2010 |
€625 |
Full
Payment received after 4 March 2010 |
€695 |
Nurses/Residents/Students
Proof of eligibility must accompany registration |
€200 |
To Register: You may register online by 4 March 2010, or by calling Imedex at +1 (678) 242 0906.
Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
Payment: To pre-register, registration and payment must be received no later than 4 March 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, congress materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 4 March 2010. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 4 March 2010.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
The Registration and Information Desk will be staffed:
Friday, 12 March 2010 7:00 – 16:40
Saturday, 13 March 2010 7:00 – 16:40
Italian Participants
Alijet & Fargo International SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Alijet & Fargo International SRL
Via Pietro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078
Le Royal Luxembourg
12, boulevard Royal
L-2449 Luxembourg, Luxembourg
Tel.: +352 24 16 16 1
Fax: + 352 22 59 48
www.hotelroyal.lu
Following the lines of the purest hotel traditions, the hotel «Le Royal» welcomes you to its 210 rooms and suites, all of which are spacious, elegant and entirely air-conditioned. Their layout has been arranged to respond to the needs and comfort of an international business and
tourist clientele.
For the convenience of attendees, a limited number of rooms have been reserved until 12 February 2010 at a discounted rate of €200.00 for single occupancy or €227.00 for double occupancy. These rates include buffet breakfast, city tax, service and V.A.T. This rate is not guaranteed outside the Congress dates or after
12 February 2010.
To reserve your room please contact the Le Royal Luxembourg reservations department at +352 24 16 16 1 or visit the hotel’s website at https://reservations.ihotelier.com/crs/g_login.cfm?hotelID=6019. To receive the group rate, callers must identify themselves as being with the 12th International Symposium on Febrile Neutropenia group. Internet users must enter the meeting promotional code: Imedex_March2010. The promotional code is case sensitive. The website is for new reservations only. If you need to change or cancel your reservation please call the hotel directly. Reservation requests received after 12 February 2010 may not be guaranteed the group rate.
Letter from the Chair
Dear Colleagues,
It is my pleasure to invite you to the 12th International Symposium on Febrile Neutropenia. For this winter’s meeting, we are delighted to be gathering in the capital city of the Grand Duchy of Luxembourg - a small country of great attractions at the very heart of Europe. We hope you will be able to join us for what is sure to be a rewarding and dynamic experience, as your perspectives and contributions add immeasurable value to this international symposium.
This scientific meeting is designed to provide medical oncologists, infectious disease specialists, and other interested healthcare professionals with the most salient aspects of the etiology, diagnosis, and state-of-the-art management of febrile neutropenia.
Topics are selected each year from recent developments in the field, current controversies and complicated cases. The highly interactive format includes 4 sessions; each comprised of a state of the art presentationlecture, followed by a cutting-edge research presentations relating to the topic, a case discussion focusing on the practical application of the topic, and a summary. There is always opportunity for extensive discussion of the presented data.
We will again be accepting abstracts for both oral and poster presentations and encourage you to submit your work by the 15 December deadline. We look forward to reviewing and sharing your research findings with the community.
Attendees have offered high praise for the quality of the scientific program and the international panel of experts in the faculty, and they have stated that participation in this conference significantly enhances their knowledge of the implications and management of febrile neutropenia. We hope you will plan to join us this year.
Warmly, Jean A. Klastersky, MD, PhD
ORGANIZER
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2009 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following company has provided an educational grant in support of this conference:
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.
The following companies will be exhibiting at this conference:
Opportunities are available to companies interested in exhibiting at this conference. For more information, please contact Cori Gunter at +1(678) 242 0712 or by email at c.gunter@imedex.com.
